New Insights into Epilepsy: From Molecular Physiology to Pathology
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 3184
Special Issue Editor
Interests: epilepsy
Special Issue Information
Dear Colleagues,
In 2002, Vezzani et al. wrote that brain inflammation is the pathophysiological cause of epileptic seizures, not a simple predisposing factor, and in 2004 Riazi et al. highlight the role of peripheral inflammation capable of migrating from the intestine to the brain. What has been called the inflammatory response is the way of communication between organs, with repair as the object of communication.
Characteristic of the inflammatory response is the cascade of cytokines, divided into pro-inflammatory ones, which produce greater necrosis, and anti-inflammatory ones which reconstruct the tissues, even more damaged by the former. Therefore, cytokines play an important role in defining the seizure threshold.
Already in 1995, altered cytokine production was evident in epileptic patients, which we now know depends on the biodiversity of the microbiota. While we are always capable of producing the first cytokines, the second ones are produced capable or unable to reconstruct tissues depending on the biodiversity of the microbiota. Furthermore, we know that cytokines are the operational arm of the microbiota with which it controls all the functions of the human body, even the functioning of organs, including the brain and immune system. It is not healthy to entrust the control of the human body to incapable cytokines, in fact this type of inflammatory response, called low-grade chronic, has been defined as the mother of pathologies.
All this leads us to consider the intestine and the microbiota as organs responsible for epileptic seizures, as was already known from Hippocrates, 400 BC, to 1930, when 50% of the treatment on epilepsy was on the ketogenic diet. We have known for some time that ketones are not responsible for its effectiveness in controlling seizures, but rather its anti-inflammatory action, modifying microbiota. Similarly, an intestinal anti-inflammatory action of antiepileptic drugs can contribute to the control of seizures. Thus, an intestinal anti-inflammatory action is reported for levetiracetam, a drug whose effectiveness was discovered causally, having not given answers to the usual tests, for Cannabidiol, and for Topiramate.
To find new therapeutic strategies, we will have to adapt ancient knowledge with current evidence, and understand what the optimal diet is to allow the microbiota to take care of us.
This Special Issue will be supervised by Dr. Paolo Mainardi, with assistance from Dr. Gianmichele Villano (University of Genova).
Dr. Paolo Mainardi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epilepsy
- molecular pathology
- disease
- therapeutic strategies
- celluar advance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
